Produto adicionado correctamente ao carrinho.

discount label
[3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-…
Ver 3D

Indagoo logo

[3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione

CAS: 114-07-8

Ref. IN-DA0039A1

5g
25,00 €
25g
52,00 €
100g
119,00 €
500g
509,00 €
Entrega estimada em Estados Unidos, Terça-feira 3 de Dezembro de 2024

Informação sobre produto

Nome:
[3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
Sinónimos:
  • Erycette
  • Erymax
  • Erythromycin
  • Erythromycin A
  • Erythromycin C
  • Erythromycin Lactate
  • Erythromycin Phosphate
  • Ilotycin
  • Lactate, Erythromycin
  • Phosphate, Erythromycin
  • Ver mais sinónimos
  • T Stat
  • T-Stat
  • erythromycin
  • Erythromycin A
  • E-Mycin
  • Abomacetin
  • Erythrocin
  • Erythromycinum
  • Erymax
  • Ilotycin
  • Erythromycine
  • Eritromicina
  • Emgel
  • Robimycin
  • Erythro-Statin
  • E-Glades
  • E-Base
  • erythro
  • Benzamycin
  • Dumotrycin
  • Mephamycin
  • Eryacne
  • Sansac
  • Eryc Sprinkles
  • Erythra-Derm
  • Akne-Mycin
  • Erythromycin base
  • R-P Mycin
  • Wemid
  • E-Solve 2
  • Torlamicina
  • Abboticin
  • Erycette
  • Ery-Tab
  • Erythroguent
  • Eritrocina
  • Erycinum
  • Erythrogran
  • Erythromid
  • Pantomicina
  • Propiocine
  • Stiemycin
  • Dotycin
  • Ermycin
  • Erycen
  • Erycin
  • Eryderm
  • Erygel
  • Ilocaps
  • Aknin
  • Pfizer-E
  • Theramycin Z
  • Kesso-Mycin
  • Taimoxin-F
  • Ak-Mycin
  • Erythromast 36
  • Erythromycin Lactate
  • T-Stat
  • Endoeritrin
  • Eritomicina
  • Erythroderm
  • Erytrociclin
  • Paediathrocin
  • Pharyngocin
  • Proterytrin
  • Acneryne
  • Acnesol
  • Aknemycin
  • Derimer
  • Deripil
  • Erisone
  • Eryacnen
  • Erydermer
  • Eryhexal
  • Erysafe
  • Iloticina
  • Latotryd
  • Lederpax
  • Mercina
  • Oftamolets
  • Pantoderm
  • Pantodrin
  • Primacine
  • Romycin
  • Stiemicyn
  • Tiloryth
  • Tiprocin
  • Emuvin
  • Emycin
  • Erecin
  • Erymed
  • Erytab
  • Erytop
  • Inderm
  • Retcin
  • AustriaS
  • Eros
  • Ery-maxin
  • Erythro-Teva
  • Sans-acne
  • Erimycin-T
  • Ery-Diolan
  • Inderm Gel
  • Del-Mycin
  • Wyamycin S
  • Aknederm Ery Gel
  • Udima Ery Gel
  • Emu-Ve
  • Erythrocin stearate
  • Skid Gel E
  • Akne Cordes Losung
  • Ilosone (estolate)
  • E-Mycin (base)
  • Ery-Tab (base)
  • E-Base (base)
  • Emu-V
  • Ery-B
  • C-Solve-2
  • IndermRetcin
  • erythromycin-A
  • A/T/S
  • Oftalmolosa Cusi Eritromicina
  • Ilotycin gluceptate
  • (-)-Erythromycin, 98%
  • (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione
  • Ilotycin T.S.
  • (-)-Erythromycin, Eur.Ph.
  • N-Methylerythromycin A
  • Ery-Sol
  • (2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3-amino-3,4,6-trideoxy-N,N-dimethyl--D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C,3-O-dimethyl--L-ribo-hexopyranosyloxy)-13-ethyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxotridecan-13-olide
  • erthromycin
  • Erythromycines
  • E-mycin, Erythrocin
  • Erythromycin(E-Mycin)
  • Erythromycin A, B + C
  • Erythromycin (mixture of A,B,C)
  • Erythromycin, labeled with carbon-13
  • Erythromycin, tested according to Ph.Eur.
  • Erythromycin, N-demethyl-N-(methyl-11C)-
  • Erythromycin, plant cell culture tested, ~98%
  • Erythromycin, Biotechnology Performance Certified
  • 9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
  • Erythromycin, Antibiotic for Culture Media Use Only
  • Erythromycin, BioReagent, suitable for cell culture
  • Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
  • (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
  • (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl propanoate (non-preferred name)
  • (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
  • (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
  • (3R,7R,9R,11R,13S,14R)-6-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
  • 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
  • Drmysin
  • E-mycin
  • E.E.S
  • EMU
  • Ergel
  • Eritocina
  • Eritrex
  • Eritromed
  • Erthrogran
  • Ery Derm
  • Ery-Ped
  • EryDerm
  • Eryc
  • Erythro
  • Erythromast
  • Ilocap
  • Ilosone
  • L-alpha-Egg-phosphatidylcholine
  • Nsc 55929
  • Oxacyclotetradecane, erythromycin deriv.
  • Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
  • Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
  • P.C.E.
  • PCE
  • Pediamycin
  • Statcin
  • Staticin
  • Torlamicna
  • Vetwic
  • Wintrocin
  • Wyamycin-s
  • [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Indagoo
Armazenamento a longo prazo:
Notas:

Propriedades químicas

Peso molecular:
733.9268
Fórmula:
C37H67NO13
Pureza:
98%
Cor/forma:
Solid
InChI:
InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
Chave InChI:
ULGZDMOVFRHVEP-RWJQBGPGSA-N
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:

Informação sobre riscos

Número ONU:
EQ:
Classe:
Frases H:
Frases P:
Proibido de voar:
Informação sobre riscos:
Grupo de Embalagem:
LQ:

Consulta técnica sobre: IN-DA0039A1 [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione

Por favor, utilize o carrinho para solicitar um orçamento ou uma encomenda

Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.

* Campos obrigatórios
Bem-vindo à CymitQuimica!Usamos cookies para melhorar sua visita. Não incluímos publicidade.

Consulte a nossa Política de Cookies para mais detalhes ou ajuste suas preferências em "Configurar".